SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : The Trump Presidency
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
Recommended by:
Brumar89
CentralParkRanger
Terry Maloney
To: i-node who wrote (201746)6/10/2021 6:55:11 PM
From: Sam3 Recommendations   of 363162
 
Man, you're an idiot. You don't even recall what you were repeatedly claiming last year.

Here is the crux of the study you are currently touting:


The observational study, published by medRxiv, found that antimalarial drug hydroxychloroquine, along with zinc, could increase the coronavirus survival rate by as much as nearly 200% if distributed at higher doses to ventilated patients with a severe version of the illness.


But last year, everyone including you was saying that HCQ would only be effective if it was taken early in the course of the disease. It wouldn't work once the person was seriously ill.

And let's not overlook the facts that (1) this is only one study, (2) it is an observational study and (3) it is a preprint and no peer reviewed.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News